Qiu L - Search Results

1

Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.

Dong L, Lv H, Li W, Song Z, Li L, Zhou S, Qiu L, Qian Z, Liu X, Feng L, Meng B, Fu K, Wang X, Pan-Hammarström Q, Wang P, Wang X, Zhang H. Dong L, et al. Among authors: qiu l. Oncotarget. 2016 May 31;7(22):33350-62. doi: 10.18632/oncotarget.9061. Oncotarget. 2016. PMID: 27147575 Free PMC article.

2

[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].

Liu XM, Wang HQ, Zhang HL, Qiu LH, Li W, Li LF, Cui XZ, Liu PF, Hao XS. Liu XM, et al. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):779-82. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173813 Clinical Trial. Chinese.

3

[Clinical characteristics and treatment analysis of primary breast lymphoma: 49 cases report].

Qiu LH, Wang HQ, Qian ZZ, Li W, Hou Y, Meng XR, Cui XZ, Hao XS. Qiu LH, et al. Zhonghua Wai Ke Za Zhi. 2010 May 15;48(10):743-6. Zhonghua Wai Ke Za Zhi. 2010. PMID: 20646489 Chinese.

4

Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.

Wang HQ, Qian ZZ, Liu XM, Zhang HL, Li LF, Qiu LH, Hou Y, Zhou SY, Hao XS, Xie CH. Wang HQ, et al. Chin Med J (Engl). 2010 Nov;123(22):3212-6. Chin Med J (Engl). 2010. PMID: 21163117 Clinical Trial.

5

[Characteristics of infection and interventional therapy strategies for malignant lymphoma patients after autologous stem cell transplantation].

Qiu LH, Wang HQ, Liu XM. Qiu LH, et al. Zhonghua Xue Ye Xue Za Zhi. 2011 Feb;32(2):132-3. Zhonghua Xue Ye Xue Za Zhi. 2011. PMID: 21429386 Chinese. No abstract available.

6

[Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].

Li LF, Wang HQ, Liu XM, Zhang HL, Qiu LH, Qian ZZ, Li W. Li LF, et al. Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):626-8. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22325226 Chinese.

7

[Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].

Hou Y, Wang HQ, Fu K, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):911-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340100 Chinese.

8

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

Hou Y, Wang HQ, Fu K, Liu XM, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):306-10. doi: 10.3760/cma.j.issn.0253-3766.2012.04.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22781046 Chinese.

9

[Epigenetics in tumorigenesis: advances and clinical implications].

Wang Xh, Zhao Xj, Qiu Lh, Wang Hq, Wang X. Wang Xh, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2012 Oct 18;44(5):701-7. Beijing Da Xue Xue Bao Yi Xue Ban. 2012. PMID: 23073578 Free article. Review. Chinese.

10

Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.

Xu Y, Wang H, Zhou S, Yu M, Wang X, Fu K, Qian Z, Zhang H, Qiu L, Liu X, Wang P. Xu Y, et al. Among authors: qiu l. Leuk Lymphoma. 2013 Jul;54(7):1396-404. doi: 10.3109/10428194.2012.743657. Epub 2012 Nov 26. Leuk Lymphoma. 2013. PMID: 23101661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,821 results

Search Page

Filters